Embolization of brain arteriovenous malformations with intent to cure: a systematic review.

AVM = arteriovenous malformation DACT = double arterial catheterization DSA = digital subtraction angiography EVD = external ventricular device MRA = MR angiography NBCA = N-butyl cyanoacrylate PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses brain arteriovenous malformation characteristics complication curative embolization endovascular embolization intent to cure outcomes vascular disorders

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 21 06 2018
accepted: 01 10 2018
pubmed: 6 2 2019
medline: 22 4 2020
entrez: 6 2 2019
Statut: ppublish

Résumé

Endovascular embolization has been established as an adjuvant treatment strategy for brain arteriovenous malformations (AVMs). A growing body of literature has discussed curative embolization for select lesions. The transition of endovascular embolization from an adjunctive to a definitive treatment modality remains controversial. Here, the authors reviewed the literature to assess the lesional characteristics, technical factors, and angiographic and clinical outcomes of endovascular embolization of AVMs with intent to cure. Electronic databases-Ovid MEDLINE, Ovid Embase, and PubMed-were searched for studies in which there was evidence of AVMs treated using endovascular embolization with intent to cure. The primary outcomes of interest were angiographic obliteration immediately postembolization and at follow-up. The secondary outcomes of interest were complication rates. Descriptive statistics were used to calculate rates and means. Fifteen studies with 597 patients and 598 AVMs treated with intent-to-cure embolization were included in this analysis. Thirty-four percent of AVMs were Spetzler-Martin grade III. Complete obliteration immediately postembolization was reported in 58.3% of AVMs that had complete treatment and in 45.8% of AVMs in the entire patient cohort. The overall clinical complication rate was 24.1%. The most common complication was hemorrhage, occurring in 9.7% of patients. Procedure-related mortality was 1.5%. While endovascular embolization with intent to cure can be an option for select AVMs, the reported complication rates appear to be increased compared with those in studies in which adjunctive embolization was the goal. Given the high complication rate related to a primary embolization approach, the risks and benefits of such a treatment strategy should be discussed among a multidisciplinary team. Curative embolization of AVMs should be considered an unanticipated benefit of such therapy rather than a goal.

Identifiants

pubmed: 30717053
doi: 10.3171/2018.10.JNS181791
pii: 2018.10.JNS181791
doi:
pii:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

388-399

Auteurs

Eva M Wu (EM)

1Department of Neurological Surgery, University of Texas Southwestern, School of Medicine; and.

Tarek Y El Ahmadieh (TY)

Departments of2Neurological Surgery and.

Cameron M McDougall (CM)

Departments of2Neurological Surgery and.

Salah G Aoun (SG)

Departments of2Neurological Surgery and.

Nikhil Mehta (N)

3Neurointerventional Radiology, University of Texas Southwestern, Zale Lipshy Hospital, Dallas, Texas.

Om James Neeley (OJ)

Departments of2Neurological Surgery and.

Aaron Plitt (A)

Departments of2Neurological Surgery and.

Vin Shen Ban (V)

Departments of2Neurological Surgery and.

Rafael Sillero (R)

Departments of2Neurological Surgery and.

Jonathan A White (JA)

Departments of2Neurological Surgery and.

H Hunt Batjer (HH)

Departments of2Neurological Surgery and.

Babu G Welch (BG)

Departments of2Neurological Surgery and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH